CIK 0001075880
- Non-accelerated filer
KAZIA THERAPEUTICS LTD
Sign in to watch- Ticker
- KZIA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- Operating
- Phone
- +61 298780088
- Business address
- THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
- Former names
- NOVOGEN LTD
- 4 Open-market sale 10% owner sold 90,025 shares at $6.21 ($559,208)
- 4 Open-market sale Director sold 3,500 shares at an average $8.92 ($31,220)
- 4 Other disposition 10% owner disposed of 17,837,246 shares (other)
- 4 Conversion 10% owner acquired 4,827,000 shares (conversion)
- 4 Option exercise 10% owner acquired 4,494,377 shares (option exercise)
- 4 Grant or award 10% owner acquired 1,941,747 shares (grant or award)
- 4 Grant or award 10% owner acquired 1,333,333 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 4,531,633 shares at $1.16 ($5,256,694)
- 4 Open-market buy 10% owner bought 2,908,295 shares at $2.17 ($6,311,000)
- 4 Open-market buy 10% owner bought 7,000 shares at $4.90 ($34,279)
- 4 Open-market buy 10% owner bought 435,039 shares at $7.76 ($3,376,773)
- 4 Open-market buy 10% owner bought 200,000 shares at $8.40 ($1,679,000)
- 4 Open-market buy 10% owner bought 24,100 shares at $8.40 ($202,440)
- 4 Open-market buy 10% owner bought 7,000 shares at $8.60 ($60,182)
- 4 Open-market buy 10% owner bought 19,427 shares at an average $8.26 ($160,532)
- 4 Open-market buy 10% owner bought 12,485 shares at an average $8.45 ($105,438)
- 4 Open-market buy 10% owner bought 5,600 shares at an average $8.55 ($47,907)
- 4 Open-market buy 10% owner bought 12,573 shares at an average $8.97 ($112,738)
- 4 Open-market buy 10% owner bought 8,000 shares at $9.35 ($74,818)
Page 2 of 5 · 84 filings